
Spending in 2011 grew at 4.6% among employer-sponsored insurance plans

Manufacturers, distributors and healthcare providers unite to address ongoing abuse

Microencapsulation of PCMs - and new PCMs - are in the offing

Companies broaden their cold-chain shipping and storage capabilities

Recommendations help pharmacies, healthcare providers and patients deal with natural disasters or power outages

Another go at altering the lagging pace of drug research

French cold-chain supplier adds to its existing European, US and Australian depots

Ferring Pharma will work with Walgreens Specialty Pharmacy for distribution and patient education

Recently published paper proposes 13 'best research practice' principles for developing and using CER results

Latest acquisitions are Bilcare Clinical Supplies and Drug Safety Alliance Inc.

InTouch Solutions, MD Mindset collaborate to tailor iPad content development

InTouch Solutions, MD Mindset collaborate to tailor iPad content development

New Institute of Medicine report calls for a data-driven, 'continuously learning' healthcare system

Company is partnering with its retail clients to market sales activity data

Syndicated study highlights role health economics and outcomes research (HEOR) teams play in drug development

Understand when total cost of care is the only winning argument - and when you can ignore it, says Oliver Wyman

Implications for pharma are in continuing pricing pressure, and preferences for distribution channels

Action adds to the increasing number of global healthcare-distribution pathways

The geriatric-dominated LTC market is growing, but has unique constraints

Deployment of Model N cloud-based IT services boosts internal capabilities at J&J

Achieving a 'clinical workflow' compatible with doctors' and hospital administrators' online preferences is the goal; will pharma promotional messaging find a place?

Elaborate testing is necessary to ensure the stability and functionality of today's drug-delivery systems

Premier, one of the leading group purchasing organizations (GPOs), is a vital linkage point between nearly 90,000 healthcare sites in the US, and the drug, device and hospital-supply vendors that serve them. Pharmaceutical Commerce sat down with Mike Alkire, chief operating officer of the company, to hear about what's driving GPO evolution today, and how it interacts with pharma manufacturers. Here's what he had to say:

Although controversial, patient-focused discounts can play a valuable role in managed-markets programs

The USP standard, currently in draft form, is an effort to provide recommendations for end-to-end supply chain integrity


Industry is not waiting for action in Washington

As payers seek higher-quality data from real-world treatment settings, the importance of reliable measures becomes critical

Design choices can make a difference in a crowded market

Orphan drug development and marketing have important distinct requirements for R&D, regulatory and marketing